These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15073697)

  • 21. Dermatan sulfate anticoagulation: future replacement for heparin?
    Gravlee GP
    J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):237-9. PubMed ID: 7669955
    [No Abstract]   [Full Text] [Related]  

  • 22. Monitoring of systemic anticoagulation during cardiopulmonary bypass.
    Bidstrup BP
    Ann Thorac Surg; 1996 Mar; 61(3):781-2. PubMed ID: 8619692
    [No Abstract]   [Full Text] [Related]  

  • 23. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low preoperative antithrombin activity causes reduced response to heparin in adult but not in infant cardiac-surgical patients.
    Dietrich W; Braun S; Spannagl M; Richter JA
    Anesth Analg; 2001 Jan; 92(1):66-71. PubMed ID: 11133602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of low vs conventional-dose heparin for minimal cardiopulmonary bypass in coronary artery bypass grafting surgery.
    Fromes Y; Daghildjian K; Caumartin L; Fischer M; Rouquette I; Deleuze P; Bical OM
    Anaesthesia; 2011 Jun; 66(6):488-92. PubMed ID: 21501130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass.
    Shirota K; Watanabe T; Takagi Y; Ohara Y; Usui A; Yasuura K
    Artif Organs; 2000 Jan; 24(1):49-56. PubMed ID: 10677157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Measurement of activated clotting time during cardiopulmonary bypass in infective endocarditis patients].
    Jiang L; Yu JF
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):167-9. PubMed ID: 17344611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin resistance and Marfan syndrome: is there any correlation?
    Choudhury M; Kiran U; Saxena N; Saxena R
    J Cardiothorac Vasc Anesth; 2002 Feb; 16(1):75-9. PubMed ID: 11854884
    [No Abstract]   [Full Text] [Related]  

  • 29. Heparin resistance.
    Bharadwaj J; Jayaraman C; Shrivastava R
    Lab Hematol; 2003; 9(3):125-31. PubMed ID: 14521318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series.
    Chryssos A; Stroup SJ; Pifer MM; Tawil M; Conrad CG
    J Extra Corpor Technol; 2015 Mar; 47(1):44-7. PubMed ID: 26390679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative antithrombin supplementation in cardiac surgery: a randomized controlled trial.
    Ranucci M; Baryshnikova E; Crapelli GB; Woodward MK; Paez A; Pelissero G
    J Thorac Cardiovasc Surg; 2013 May; 145(5):1393-9. PubMed ID: 23102903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
    Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrinsic pathway--associated activated clotting time for anticoagulation monitoring during cardiopulmonary bypass.
    Gu YJ; Huyzen RJ; van Oeveren W
    Anesth Analg; 1996 Aug; 83(2):433. PubMed ID: 8694335
    [No Abstract]   [Full Text] [Related]  

  • 35. Con: The Hepcon HMS Should Not Be Used Instead of Traditional Activated Clotting Time to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass.
    Gilly G; Trusheim J
    J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1730-1732. PubMed ID: 27751763
    [No Abstract]   [Full Text] [Related]  

  • 36. Paraprotein associated heparin resistance during cardiopulmonary bypass.
    Khuong JN; Forsyth CJ; Manuel L; Kingsford-Smith K; Srivastava A; Bassin L
    Perfusion; 2023 Sep; 38(6):1319-1321. PubMed ID: 35700111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful Antithrombin Administration in Andexanet Alfa-Associated Heparin Resistance.
    Apostel HJCL; Winckers K; Bidar E; Schreiber JU
    J Cardiothorac Vasc Anesth; 2021 Mar; 35(3):904-907. PubMed ID: 33187852
    [No Abstract]   [Full Text] [Related]  

  • 38. Identifying optimal heparin management during cardiopulmonary bypass in obese patients: A prospective observational comparative study.
    Haas E; Fischer F; Levy F; Degirmenci SE; Grunebaum L; Kindo M; Collange O; Mertes PM; Steib A
    Eur J Anaesthesiol; 2016 Jun; 33(6):408-16. PubMed ID: 26886138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
    Kanbak M
    Can J Anaesth; 1999 Jun; 46(6):581-5. PubMed ID: 10391608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo effects of hemodilution on kaolin-based activated clotting time predicted heparin requirement using a heparin dose-response technique.
    Ichikawa J; Hagihira S; Mori T; Kodaka M; Nishiyama K; Ozaki M; Komori M
    J Anesth; 2016 Dec; 30(6):923-928. PubMed ID: 27502398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.